x

Important Notice: We have upgraded our website. If you are a returning member, to access your account, please reset your password.

The CME Portal is still under construction. That section will be available soon.

Anthony Tufaro, D.D.S., M.D., F.A.C.S.

Anthony Tufaro was born and raised in New York City. Dr. Tufaro obtained his Dental Degree from N.Y.U. College of Dentistry. He then did a residency in Oral and Maxillofacial Surgery at Nassau County Medical Center. He received his medical degree from Hahnemann University School of Medicine in Philadelphia, Pa.. Following graduation for medical school he trained in General Surgery and Plastic & Reconstructive Surgery at the Johns Hopkins Hospital. Following this, he went to Memorial Sloan-Kettering Cancer Center in New York for a Fellowship in Surgical Oncology specializing in Head and Neck Tumors. Upon returning to Hopkins after his fellowship he developed an active practice in the management of benign and malignant tumors of the head and neck including thyroid and parathyroid lesions and also lectured and published extensively on his experience in major reconstruction of the chest and abdomen.. After 25 years on faculty at Hopkins he was recruited to OU as the Chief of Plastic Surgery. Currently he is the Chief of Plastic Surgery at the Oklahoma City VA. He is board certified in Oral & Maxillofacial Surgery and Plastic & Reconstructive Surgery. He has authored or co-authored over 100 peer reviewed papers and textbook chapters and is an invited lecturer nationally and internationally. His basic science lab is working to elucidate the mechanisms behind the initiation and progression of aggressive cutaneous malignancies. Dr. Tufaro has been recipient of the Castle Connolly Top Doctors for Cancer award for over a decade.

Current Management of Non-Melanoma Skin Cancers

Objectives:

  • Identify the most common cutaneous malignancies.
  • Summarize the recommended management of each type. Including margin required for cure, nodal evaluation and possible staging work up.
  • Discuss the indications for adjuvant therapy.
  • Discuss the increasing incidence in aggressive cutaneous malignancies.
  • Discuss surveillance strategies for patients with aggressive cutaneous malignancies.